Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a software version update for the site rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:38.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no active enrollment. New help sections are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header is updated alongside a revision tag advancing to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T14:08:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.5.5 has been added to the page. The previous revision tag Revision: v3.5.4 has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T09:27:17.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, signaling a new page version was published; such updates typically reflect editorial or backend adjustments rather than changes to essential content.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2, indicating a minor backend/content update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:23:56.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2; no visible changes to page content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-04-16T11:00:44.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.